BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
PHGE.WS was delisted on the 1st of June, 2023.
0 hedge funds and large institutions have $0 invested in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $63
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Clear Street
New York
|
-$63 |
PHGE.WS Hedge Fund Activity: Q3 2023 in Review
0 of the 6,314 institutional investors tracked by Wall St. Rank reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) for Q3 2023, worth a combined $0 — down 100% from $63 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PHGE.WS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Clear Street, exiting entirely with an estimated $63 sold.
- 0 institutional investors held BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) as of Q3 2023, down from 1 in Q2 2023.
- Funds reported $0 of BiomX Inc. Warrants to purchase one-half of a share of Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new BiomX Inc. Warrants to purchase one-half of a share of Common Stock positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest BiomX Inc. Warrants to purchase one-half of a share of Common Stock seller in Q3 2023 was Clear Street, an estimated $63 sold.
Based on aggregated 13F filings for Q3 2023.